Sandoz approval for generic Ozempic in Canada draws mixed outlook
TradingView News market talk says Sandoz’s Canada approval for a generic version of Novo Nordisk’s Ozempic is positive, but RBC Capital Markets says the size of the upside is difficult to gauge.